The Real Cost of a Milligram: Building a Landed-Cost Sheet for UK CBD Wholesale
Photo: Paul Collins, CC BY-SA 2.0, via Wikimedia Commons
The quote is not the cost
UK retailers comparing CBD oil quotes often focus on the price per bottle. That is understandable, because it is the number printed on the wholesale schedule. It is also incomplete. A lower unit price can conceal lower potency, wider batch variance, missing testing, inadequate packaging or compliance work that has been left to the buyer.
The more useful metric is landed cost per milligram of CBD in saleable product. This figure allows a retailer to compare quotes across bottle sizes, potency levels, batch sizes and supplier terms. It also exposes false economies before stock is ordered.
Building the worksheet
Start with the invoice cost, then add every cost incurred before the product is ready to sell. The basic formula is:
Landed cost per mg = (invoice + freight and insurance + duty and clearance + third-party testing + compliance + packaging + waste allowance + financing) divided by (saleable bottles × labelled mg × potency factor × (1 - waste rate)).
The potency factor is measured mg divided by labelled mg. If a batch tests at 95 per cent of label, the factor is 0.95. If it tests above label, the factor is above 1.00, but buyers should not rely on overage unless it is contractually guaranteed. The waste rate covers fill losses, damaged units, retention samples and short-dated stock.
| Cost line | What to include | Common omission |
|---|---|---|
| Invoice | Unit price multiplied by quantity | Assuming every unit will be saleable |
| Freight and insurance | Inbound transport, insurance, pallet handling | Ignoring damage or delay costs |
| Duty and clearance | Customs duty, clearance fees, import processing | Assuming ex-works pricing is final |
| Third-party testing | Potency, cannabinoid, THC, contaminants, residual solvents | Testing only one batch per pallet |
| Compliance | Label review, specification files, novel food evidence, claims review | Treating paperwork as free |
| Packaging | Bottle, dropper, label, carton, tamper seal | Underestimating artwork and line trials |
| Waste | Fill loss, damaged stock, retain samples, expiry write-off | Using invoice cost as the full cost base |
| Financing | Payment terms, currency exposure, storage | Ignoring the cost of cash tied up in stock |
A worked illustration
The following figures are illustrative only and should be replaced with actual quotes. Assume 1,000 bottles, a label claim of 500 mg per bottle, an invoice price of £5.00 per bottle, freight and insurance of £180, testing at £300 per batch, compliance work at £200, packaging at £0.45 per bottle, a waste allowance of £220 and financing of £100.
Total landed cost is £5,000 plus £180 plus £300 plus £200 plus £450 plus £220 plus £100, or £6,450. If the measured potency factor is 0.96 and the waste rate is 4 per cent, saleable CBD is 1,000 × 500 × 0.96 × 0.96, or 460,800 mg. Landed cost per mg is therefore £6,450 divided by 460,800 mg, or about 1.4p per mg.
That figure is more decision-useful than the bottle price. It can be recalculated when a supplier offers a lower unit price but a wider potency tolerance, or a higher price with a tighter specification and better packaging.
Potency variance changes the comparison
A quote for 500 mg bottles is not equivalent to a guarantee of 500 mg in every bottle. If the supplier tests at 475 mg and applies a broad tolerance, the retailer is paying for milligrams that are not present. If the supplier consistently overfills, the buyer may receive more CBD than the label states, but that overage should be treated as a buffer, not as a pricing assumption.
Ask whether the price is based on minimum guaranteed potency, average potency or label claim. Ask for the batch CoA before shipment and agree a rejection right if results fall outside an agreed range. A supplier that cannot state its potency tolerance is transferring risk to the retailer.
Testing and compliance are real cost lines
Third-party testing is not a one-off formality. Potency, THC, residual solvents, pesticides, heavy metals and microbial results should be batch-specific. Small orders may carry a disproportionately high testing cost per unit, which is why a cheap quote for a small batch can be more expensive per milligram than a larger, better-documented batch.
Compliance work includes label review, specification files, claims checks and evidence of novel food compliance. In the UK, CBD extracts are treated as novel foods, and retailers should be able to show that the products they sell are supported by appropriate authorisation and labelling. Missing paperwork can lead to rework, delisting or reputational damage, all of which belong in the landed-cost model as risk costs.
Packaging, waste and MOQ
Packaging should be specified, not assumed. Bottle weight, dropper performance, label durability, carton strength and tamper evidence all affect damage rates and customer returns. A line trial may be advisable before a large order.
Minimum order quantities create their own arithmetic. A price break at 5,000 units is only useful if the stock will sell before expiry and if storage and financing costs are included. Short-dated stock is a waste cost even when the invoice price looks attractive. Buyers should ask for batch age, remaining shelf life and a replacement or credit policy for damaged or out-of-specification stock.
Negotiation points that change the landed cost
- Ask for a price per milligram at guaranteed potency, not only a price per bottle.
- Require a batch-specific CoA before shipment and agree a potency tolerance with rejection rights.
- Clarify who pays for testing, retests and pre-shipment samples.
- Confirm the packaging specification and who bears the cost of damage in transit.
- Negotiate call-off schedules or staged deliveries rather than accepting a large MOQ outright.
- Request the compliance pack, including label copy and novel food evidence, before approving artwork.
- Agree payment terms, lead times and shelf-life minimums in writing.
- Compare replacement and credit policies, not just the headline unit price.
The disciplined conclusion
The cheapest quote is not the same as the lowest landed cost per milligram. A retailer that models potency, testing, compliance, packaging, waste and financing can compare suppliers on a like-for-like basis and negotiate from evidence rather than impression. In a market where label claims and batch quality vary, that discipline is not administrative excess. It is the basis of a defensible wholesale buying decision.
